United States · Platforms & data · Yahoo Finance

Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?

Published by Yahoo Finance · United States 8 h ago

Drug Problem Bristol-Myers Squibb Company (NYSE:BMY) reported positive data from its radiopharmaceutical RYZ101 Phase III ACTION-1 trial and additional progress across multiple…

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

The Motley Fool

Washington Trust (WASH) Q3 2026 Earnings Call Transcript

MarketWatch

It’s not just California’s billionaire tax. Wealth is on the ballot in the midterm elections.

Seeking Alpha

Silvercorp slides as Q2 revenue fell on lower Ying production following safety-related disruption

Investing.com

Earnings call transcript: Physitrack posts record Q3 2026 revenue as stock rises

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

CNBC